• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Novacyt S.A. (NCYT)

EUR1/15TH (CDI)
Sell: 42.50p|Buy: 43.20p|Change: 0 (0%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Company profile

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, Yourgene Health and Corporate. Majority of the revenue is generated from Yourgene Health segment. Geographically, the company operates in United Kingdom, France, Europe, America, Asia-Pacific, Middle East and Africa generating majority from Asia- pacific region.

Address

13, Avenue Morane Saulnier
Velizy-Villacoublay
FRA
78140

Telephone

+33 139465104

Website

https://www.novacyt.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Novacyt SA Annual General Meeting for 20272027-06-30T11:00:00
Novacyt SA Fourth Quarter Earnings Conference Call for 20262027-04-30T10:00:00
Novacyt SA Fourth Quarter Earnings Results for 20262027-04-30T00:00:00
Novacyt SA Annual Report for 20262027-04-30T00:00:00
Novacyt SA Second Quarter Earnings Results for 20262026-09-30T00:00:00
Novacyt SA Second Quarter Earnings Conference Call for 20262026-09-30T00:00:00

Previous key dates

NameKey Date
Novacyt SA Annual General Meeting for 20262026-06-30T11:00:00
Novacyt SA Fourth Quarter Earnings Conference Call for 20252026-04-30T10:00:00
Novacyt SA Fourth Quarter Earnings Result for 20252026-04-30T00:00:00
Novacyt SA Annual Report for 20252026-04-30T00:00:00
Novacyt SA Second Quarter Earnings Result for 20252025-09-30T00:00:00
Novacyt SA Second Quarter Earnings Conference Call for 20252025-09-30T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.